Prevalence of Candida dubliniensis fungemia at a large teaching hospital.
Six cases of Candida dubliniensis fungemia were identified during an 8-month period in hospitalized patients with various conditions, including human immunodeficiency virus infection. Peptide nucleic acid fluorescent in situ hybridization analysis was used as a rapid and reliable test for differentiating C. dubliniensis from Candida albicans, making it feasible to determine the prevalence of C. dubliniensis fungemia.
Jabra-Rizk
Mary Ann
MA
Department of Diagnostic Sciences and Pathology, Dental School, University of Maryland, Baltimore, MD 21201, USA. mar002@dental.umaryland.edu
Johnson
Jennifer K
JK
Forrest
Graeme
G
Mankes
Kristina
K
Meiller
Timothy F
TF
Venezia
Richard A
RA
D000328:Adult; D000935:Antifungal Agents / Q000627:therapeutic use; D002177:Candidiasis / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology*; D002675:Child, Preschool; D005260:Female; D016469:Fungemia / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology*; D006761:Hospitals; D006801:Humans; D017404:In Situ Hybridization, Fluorescence / Q000379:methods; D008297:Male; D008875:Middle Aged; D020135:Peptide Nucleic Acids; D015995:Prevalence
D000935:Antifungal Agents; D020135:Peptide Nucleic Acids